Law360, New York (April 17, 2009) -- The brokerage division of Citigroup Inc. has been hit with a $30 million lawsuit by a specialty pharmaceutical company alleging that the firm sold it auction rate securities after the market collapsed and just a day before settling charges with federal regulators over the toxic financial instruments.
Braintree Laboratories Inc. filed a complaint against Citigroup Global Markets Inc. and its Citi Smith Barney division in the U.S. District Court for the District of Massachusetts on Thursday, accusing...
